ロード中...
Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma
Systemic therapy strategies in the setting of localized and locally advanced renal cell carcinoma (RCC) have continued to evolve in two directions: as adjuvant therapy (to reduce risk of recurrence or progression in high risk localized groups), or as neoadjuvant therapy as a strategy to render prima...
保存先:
| 出版年: | J Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463563/ https://ncbi.nlm.nih.gov/pubmed/31057615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7309205 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|